Delivery Order SPE2DE22D0008-SPE2D625F0DS2
Award Date 6/2/25
Potential Completion Date 8/6/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Alba Bioscience, Inc. received a $2,030 firm fixed-price delivery order from the Department of Defense's Medical Supply Chain on June 5, 2025, for the ALBACYTE Antibody ID Panel (16-Cell). The contract, which carries an ultimate completion date of August 11, 2025, was awarded without a set-aside designation, reflecting Alba Bioscience's competitive standing as a supplier of specialized in vitro diagnostic products. Performance will take place in Chicago, Illinois, where the vendor maintains...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order contract to Alba Bioscience, Inc. for ALBACLONE anti-FYB antibody screening products. The contract, valued at $12,875 with a firm fixed price structure, was executed on September 4, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside award represents a continuation of Alba Bioscience's established role as a critical supplier of specialized in vitro diagnostic...
- Alba Bioscience, Inc. was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain division on August 14, 2025, for the supply of ALBACLONE Anti-D Blend, a specialized blood bank reagent used in immunohematology testing. This firm fixed-price contract carries a ceiling value of $1,464.00 with an ultimate completion date of August 19, 2025. The contract was awarded on a non-competitive basis with no set-aside designation, reflecting Alba Bioscience's established...
- This is a delivery order contract awarded by the Defense Logistics Agency's Medical Supply Chain division to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract, valued at $10,683.00, is for the delivery of ALBACYTE antibody identification panels and is a firm fixed-price agreement with a completion date...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization based in Chicago, Illinois, that specializes in the production and distribution of in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials for federal healthcare systems. The contract, worth $1,118.00, is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 22, 2025. The contract is funded by the Defense Logistics Agency (DLA),...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking products. The contract, worth $1,740.00, is a delivery order under contract SPE2DE22D0008|SPE2D625F15SJ, awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract is for the supply of ALBACYTE Antibody ID Panels, which are specialized 16-cell panels used for antibody identification in blood banking operations. This contract does...
- This federal contract award, valued at $1,281.00, was issued to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, with a period of performance through July 23, 2024, is a delivery order placed by the Defense Logistics Agency Troop Support Medical. The contract is for the provision of ALBACYTE Antibody Screen...
- This federal contract award is for the delivery of ALBACYTE antibody screening (3-cell) products to the Defense Logistics Agency (DLA). The contract, valued at $1,281.00, was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other biomedical products to various federal agencies, including the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS). The...
- This federal contract award SPE2DE22D0008|SPE2D625F22W7 was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, and quality control materials. The $5,160.00 firm fixed-price delivery order contract is for the provision of ALBACYTE antibody identification panels, a critical product supporting blood banking operations across federal healthcare systems. Alba Bioscience, a...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Medical Supply Chain to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to federal agencies. The $7,280.00 contract is for the delivery of ALBACYTE IGG Sensitized Cells II products to support diagnostic testing, blood typing, and transfusion services for federal healthcare...